Description

Morphinan-7-Ol, 5,6,8,14-Tetradehydro-6-Methoxy-17-Methyl-2,3-[Methylenebis(Oxy)]-, (7α)- (9Ci) is a high-purity, structurally complex organic compound belonging to the morphinan class of alkaloids. This compound is of significant interest for advanced pharmaceutical research and development, particularly in the study of central nervous system (CNS) activity and receptor binding. It serves as a critical synthetic intermediate or reference standard for medicinal chemists and analytical laboratories. Target industries include pharmaceutical R&D, contract research organizations (CROs), and manufacturers of active pharmaceutical ingredients (APIs) and fine chemicals.

Application

• Pharmaceutical Research Intermediate: A key building block in the synthetic pathway for novel therapeutic agents targeting neurological pathways.
• Reference Standard for Analytical Testing: Used in HPLC, GC-MS, and NMR for method development, validation, and quality control of related compounds.
• Medicinal Chemistry Studies: Employed in structure-activity relationship (SAR) studies to explore modifications of the morphinan scaffold for enhanced efficacy or reduced side effects.
• Biochemical Research: Utilized in in vitro assays to investigate interactions with opioid receptors and other biological targets.
• Process Development: Serves as a standard for scaling up and optimizing synthetic routes in fine chemical and API manufacturing.
• Academic Research: Used in university and institutional labs for pharmacological and chemical research projects.

Basic Information

Product Name	Morphinan-7-Ol, 5,6,8,14-Tetradehydro-6-Methoxy-17-Methyl-2,3-[Methylenebis(Oxy)]-, (7α)- (9Ci)
CAS No.	402469-62-9
Molecular Formula	C19H21NO4
Molecular Weight	327.38 g/mol
Synonyms	5,6,8,14-Tetradehydro-6-methoxy-17-methyl-2,3-methylenedioxy-7α-morphinan; 2,3-Methylenedioxy-6-methoxy-17-methyl-5,6,8,14-tetradehydromorphinan-7-ol; 7α-Hydroxy-6-methoxy-17-methyl-2,3-methylenedioxy-5,6,8,14-tetradehydromorphinan; A derivative of 7α-Hydroxy-6-methoxy-2,3-methylenedioxymorphinan; (7α)-5,6,8,14-Tetradehydro-6-methoxy-17-methyl-2,3-(methylenebis(oxy))morphinan-7-ol
EINECS	Contact for details

Quality Control

Our production of Morphinan-7-Ol, 5,6,8,14-Tetradehydro-6-Methoxy-17-Methyl-2,3-[Methylenebis(Oxy)]-, (7α)- (9Ci) adheres to stringent quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, IR and NMR for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with every shipment, ensuring traceability and compliance with your research or development specifications. Our quality commitment supports applications requiring high-purity reference standards and pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and should be handled under appropriate conditions to maintain stability. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Individual impurity ≤ 0.5% Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.